Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
India is promoting holistic healthcare with emphasis on preventive care
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
The companies will work with investigators to share the results with the scientific community
Subscribe To Our Newsletter & Stay Updated
